Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05462886 Completed - Healthy Clinical Trials

Clinical Performance of Masimo INVSENSOR00057 for Heart Rate Measurements

Start date: July 8, 2022
Phase: N/A
Study type: Interventional

This study is designed to compare the accuracy of a noninvasive measurement of heart rate compared to reference values obtained by a standard of care ECG monitor.

NCT ID: NCT05462366 Recruiting - Healthy Clinical Trials

Omics Sequencing of Specimen Derived From Mother-Infant-Pairs

Start date: June 22, 2021
Phase:
Study type: Observational

The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.

NCT ID: NCT05461443 Completed - Healthy Clinical Trials

Lacticaseibacillus Rhamnosus GG Pili Study

Start date: March 31, 2016
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the host-microbe interaction effects of various Lacticaseibacillus rhamnosus GG strains, with different binding capacities to the mucus in the small intestine, in healthy individuals

NCT ID: NCT05460754 Completed - Healthy Clinical Trials

Impact of Beef on Metabolites and Inflammation

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

Western omnivore diets tend to use beef as a good source of protein. Studies have shown cattle who are fed different diets results in varying nutritional meat profiles in terms of amino acids, types and relative amounts of fat, and other nutrients. While overlap between organic and conventionally raised beef is expected, dietary impacts on human health are potentially meaningful as small changes in diet may have large downstream effects on human metabolism. To date, no studies have been conducted in humans that evaluate the health effects of organic grass-fed beef consumption to conventionally-fed beef consumption. To fill this gap in research, the investigators propose to identify metabolic differences in response to consumption of organic grass-fed compared to conventional-fed beef on a wide array of blood borne nutrients including amino acids, lipids, bile acids, and hundreds of other metabolites. This comprehensive analysis is expected to differentiate nutritional and metabolic impacts relevant to human health and provide a foundation for future research. The purpose of this study is to determine how a beef steak meal may affect bile acids in the gut, inflammation, and the metabolic health of healthy individuals. This research will investigate the following questions: 1. How do specific foods affect bile acids in the blood? 2. How do specific foods changes inflammation, metabolism, and other health measures? If researchers learn how food affects different health related markers in the blood and how that may influence health, then this information can be used to do more research to improve the health of people in a future study.

NCT ID: NCT05460585 Completed - Healthy Clinical Trials

Cerebral Oxygenation Values in Healthy Adults Volunteers Measured With RheoPatch and NIRO-200NX

Start date: June 1, 2022
Phase:
Study type: Observational

Noninvasive measurement of cerebral tissue oxygen saturation levels by near infrared spectroscopy (NIRS) is clinical routine in perioperative medicine. One of the main technical challenges of NIRS measurements is to eliminate the influence of signals of the skin and skull. A new device (RheoPatch, Luciole Medical AG, Zurich) has been developed by a company that also developed an intracranial NIRS probe, which allowed measurements directly in the brain and thus improved algorithms for elimination of the extracranial signals. The investigators aim to determine baseline values and performance of the new device (RheoPatch) compared with a more established NIRS device (NIRO-200NX, Hamamatsu Phototonics, Hamamatsu City, Japan)

NCT ID: NCT05460455 Completed - Healthy Clinical Trials

A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants

Start date: October 13, 2022
Phase: Phase 1
Study type: Interventional

The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following multiple-dose.

NCT ID: NCT05459662 Completed - Healthy Clinical Trials

Impact of Consuming a Plant-based Enriched Meal on the Adult Gut Microbiome

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of a diversified plant-based meal on the gut microbiome and its composition.

NCT ID: NCT05457907 Recruiting - Healthy Clinical Trials

Ultrasound Therapy Effects to Modulate the Inflammatory Reflex

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This two treatment group study, including sham treatment, attempts to measure how ultrasound frequency, duration, intensity, and duty cycle impact its acute anti-inflammatory effect in healthy volunteers. It also attempts to contribute to the evidence regarding the comfort and safety of using therapeutic ultrasound. This pilot dose-finding study will be the basis for a larger Phase 2 trial in Rheumatoid Arthritis (RA) patients.

NCT ID: NCT05457543 Recruiting - Healthy Clinical Trials

Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests

Start date: June 30, 2022
Phase:
Study type: Observational

This is an observational study exploring the performance of a novel point-of-care diagnostic testing platform designed to quantitate the presence of liver function biomarkers such as bilirubin. Blood samples will be collected from participants to further development and validation of the testing platform to support FDA review. The diagnostic device is intended to provide rapid in-office test results using a finger stick of blood, a reaction test device, and a smartphone app.

NCT ID: NCT05456490 Recruiting - Healthy Clinical Trials

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

Start date: April 18, 2023
Phase: Phase 1
Study type: Interventional

Primary Objective: To assess the safety and tolerability of Liposomal Bupivacaine 13.3 administered as a single intrathecal injection in healthy volunteers. Secondary Objective: To characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profile of Liposomal Bupivacaine 13.3 administered as a single intrathecal injection in healthy volunteers.